Abstract: A user equipment (UE) receiving, from a base station (BS), a higher layer signal including first information used for configuring more than one sets of one or more downlink component carriers (DCCs). The UE receives, using a PDCCH in a first subframe, from the BS, downlink control information (DCI) including second information indicating a trigger for a transmission of channel state information (CSI), the transmission of the CSI being triggered for one set of the more than one sets of one or more DCCs, the DCI being used for scheduling of a PUSCH in one uplink component carrier. The UE transmits, using the PUSCH in a second subframe, to the BS, the CSI for the one set of the more than one sets of one or more DCCs in a case that the DCI including the second information indicating the trigger for the transmission of the CSI is received.

Abstract: A wireless communication system in which a first base station apparatus and a second base station apparatus communicate with a terminal apparatus. The first base station apparatus transmits, to the terminal apparatus, data control information related to data transmission and reception of the terminal apparatus and preferential base station apparatus information indicating a priority of data transmission to the base station apparatus, and the terminal apparatus determines any base station apparatus of the first base station apparatus and the second base station apparatus, as a data transmission destination base station apparatus, for data to which bearer split is configured by the data control information, based on at least one of the preferential base station apparatus information and terminal information of the terminal apparatus.

Abstract: In a communication system, an image forming apparatus sends an address of a receiving section to an external device. The external device receives a selection of image data through plural thumbnails displayed on a display section, and wirelessly sends the selected image data to the image forming apparatus with the address. The image forming apparatus receives the selected image data and prints an image. The image forming apparatus accepts a selection indicating whether a communication between the external device and the image forming apparatus is performed either by a first or second communication system method. The image forming apparatus performs sending and/or receiving the image data with the address by the first communication system method when the first communication system method is selected, and performs sending and/or receiving the image data with the address by the second communication system method when the second communication system method is selected.

Abstract: The occurrence of a color irregularity in light that is emitted from a light-emitting device is suppressed together with being able to prevent a decline in the utilization efficiency of excitation light. A light-emitting device is provided with a phosphor section that absorbs excitation light and emits first fluorescence, and a phosphor section that absorbs excitation light that has passed through the phosphor section without being converted into first fluorescence by the phosphor section and emits second fluorescence. Also, the peak wavelength of the second fluorescence is approximate to the peak wavelength of the excitation light.

Abstract: In its many embodiments, the present invention provides certain C-6 spirocarbocyclic iminothiadiazine compounds, including compounds Formula (I): or a tautomers thereof, and pharmaceutically acceptable salts of said compounds and said tautomers, wherein R1, R4, ring A, RA, m, L1, and RL are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.

Abstract: The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.

Abstract: The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) (I), or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring A, and the subscripts n1, n2, and r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).

Abstract: In order to realize display control of a display panel in which gate signals and source signals are supplied to the display panel via only one side of the display panel, a display device (1) includes a driving module (12) including: input terminals via which input signals from an input signal generating section (13) are supplied; output terminals via which gate signals and source signals are outputted; a gate driving circuit for generating the gate signals; and a source driving circuit for generating the source signals, and a display panel (11) in which control terminals are provided on only one side of the display panel (11).

Abstract: Provided is a liquid crystal display apparatus employing a drive method whereby nonuniform electric field is not generated in pixels. This liquid crystal display apparatus is provided with a first substrate, a first electrode, a second electrode, a second substrate, a common electrode, a counter electrode, a liquid crystal layer, and a drive unit. The drive unit executes drive operations including: operations of setting the potential of the first electrode at a low level, the potential of the second electrode at a high level, and the potential of the counter electrode at the high level; operations of setting the potential at the high level, the potential at the low level, and the potential at the high level; operations of setting the potential at the low level, the potential at the high level, and the potential at the low level; and operations of setting the potential at the high level, the potential at the low level, and the potential at the low level.

Abstract: A light-emitting device capable of ensuring an electric connection between a light-emitting element and an electrode without generating any problem in practical use, by both connecting methods with a solder and a connector, and a lighting device provided with the light-emitting device are provided. The light-emitting device according to the present invention has a plurality of LED chips, and a soldering electrode land and a connector connecting electrode land electrically connected to the chips, on a ceramic substrate. The soldering electrode land is formed of a first conductive material having a function to prevent diffusion to a solder, and the connector connecting electrode land is formed of a second conductive material having a function to prevent oxidation.

Abstract: Compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosterone-mediated diseases are disclosed. Processes for preparing compounds of the Formula (I), use of the compounds for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and pharmaceutical compositions which comprise compounds of the Formula (I) are disclosed.

Abstract: The present invention provides a liquid crystal display device that sufficiently reduces image sticking, by forming a polymer layer with stable alignment control appropriately. In a method for manufacturing the liquid crystal display device of the present invention, base film forming conditions are different between the step of forming a base film on a substrate including an active element and the step of forming a base film on a substrate different from the substrate including an active element.

Abstract: A terminal apparatus in a communication system that includes a base station apparatus and the terminal apparatus. The terminal apparatus is configured to receive a transmission configuration of an uplink control channel. In addition, the terminal apparatus is configured to transmit the uplink control channel based on a first transmission configuration or a second transmission configuration, wherein the second transmission configuration includes an extended parameter of the first transmission configuration, and the uplink control channel is used for a scheduling request.

Abstract: There is provided a wiring connection structure connecting a transparent conductive film formed on a main surface of a transparent substrate having the main surface and a metal wiring formed on the main surface and made of a metal material, wherein the metal wiring is formed to extend from the main surface onto the transparent conductive film and to cover the transparent conductive film.

Abstract: In a liquid crystal display device (100) according to an embodiment of the present invention, a plurality of color display pixels (CP) include three or more pixels (P) which exhibit different colors. The pixels (P) include a first sub-pixel (SP1) electrically connected to a first source bus line (SA) via a first TFT (T1) and a second sub-pixel (SP2) electrically connected to a second source bus line (SB) via a second TFT (T2).

Abstract: The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

Abstract: The present invention provides novel imidazole analogs of Formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

Abstract: A mobile station apparatus that includes a controller that reduces transmission power in case that data is transmitted simultaneously and a transmission circuit that simultaneous transmits said data using a plurality of channels, where the plurality of channels consists of at least one physical uplink control channel and at least one physical uplink shared channel. The transmission circuit of the mobile station apparatus also transmit hybrid automatic repeat request control information on said at least one physical uplink shared channel and also transmits channel state information on said at least one physical uplink control channel.

Abstract: The invention encompasses a novel process for making piperidinone carboxamide indane and azainane derivatives, which are CGRP receptor antagonists useful for the treatment of migraine, utilizing a highly effective spiroacid synthesis.

Abstract: The inputted character candidate display section (1213)/inputted character string candidate display section (1214) cause candidates of a character/character string, which is predicted as an intended character/character string to be inputted by the user, to be displayed as inputted character candidates/inputted character string candidate, and the converted character string candidate display section (1215) causes converted character string candidates, which have been obtained by converting the inputted character string candidate, to be displayed.